Organon & Co | OGN - SCHULD

Aktienkurs
8.83
Täglich Wechseln
1.92 27.79%
Monatlich
37.97%
Jährlich
-20.91%
Q2 Prognose
8.59




SCHULD Veränderung Datum
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Celltrion KRW 171.09B 2.05T 2025-06
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Gilead Sciences USD 24.94B 5M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Merck USD 41.37B 5.97B 2025-09
Neuren Pharmaceuticals AUD 0 0 2024-12
Novartis USD 32.02B 615M 2025-09
Organon & Co USD 8.83B 68M 2025-09
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 49.42M 1.98M 2025-12
Qiagen NV USD 2.13B 683.16M 2025-09
Sartorius EUR 4.66B 25.7M 2025-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tilray USD 640.95M 35.17M 2022-06